The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis ...
The Sackler family and its company, Purdue Pharma, reached a settlement with a coalition of 15 states in relation to their involvement in the United States opioid crisis. If approved, the January ...
Purdue Pharma and its Sackler family owners have reached a new $7.4 ... Pacific Press/LightRocket via Getty Images Under the new settlement, the Sacklers will pay $7.4 billion, without fully ...
Jan. 23 (UPI) --The Sackler family and Purdue Pharma have agreed to pay a $7.4 billion settlement to end federal court claims filed by attorneys general on behalf of 15 states. New York Attorney ...
OxyContin is widely acknowledged to have catalysed the national opioid crisis in the US. Image credit: Shutterstock/ PureRadiancePhoto. Purdue Pharma and its owners, the Sackler family, have reached a ...
Purdue Pharma, the makers and marketers of the highly addictive opioid OxyContin, and the family that owned the company, the Sackler family, have agreed to pay $7.4 billion to individuals ...
Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The Sackler family and the opioid maker they founded, Purdue Pharma, have together agreed to pay $7.4bn to ...
Purdue Pharma and its owners, the Sackler family, reached a settlement of up to $7.4 billion for its role in the opioid crisis, less than a year after the Supreme Court tossed out a proposed $6 ...
A multistate agreement regarding ongoing legal action against members of the Sackler family and their former company, Purdue Pharma, which made OxyContin, is nearing fruition. | Toby Talbot ...
The Justice Department argued that shielding the… OxyContin maker Purdue Pharma can start its transformation under a bankruptcy agreement that allows the members of the wealthy Sackler family ...